Skip to main content

Table 1 Clinical periodontal parameters of the study groups at different time intervals

From: The clinical efficacy of injectable platelet-rich fibrin (i-PRF) as an adjunct to nonsurgical periodontal therapy in smokers with periodontitis

Periodontal index

Test group

(mean ± SD)

Control group

(mean ± SD)

P value

TQHPI

   

 T0

2.60 ± 0.83

2.54 ± 0.73

0.788

 T1

0.52 ± 0.95

0.88 ± 0.98

0.090

 T2

0.56 ± 0.73

0.80 ± 0.80

0.254

 P value

< 0.001a, b

< 0.001a, b

 

GI

   

 T0

1.90 ± 0.25

1.88 ± 0.30

0.951

 T1

0.28 ± 0.60

0.6 ± 0.72

0.061

 T2

0.08 ± 0.28

0.4 ± 0.58

0.017

 P value

< 0.001a, b

< 0.001a, b

 

BOP (%)

   

 T0

90.00 ± 25.00

90.00 ± 25.00

1.000

 T1

10.00 ± 25.00

28.00 ± 32.53

0.020

 T2

4.00 ± 13.84

20.00 ± 28.87

0.017

 P value

< 0.001a, b

< 0.001a, b

 

PD (mm)

   

 T0

5.92 ± 1.12

5.56 ± 1.10

0.067

 T1

2.66 ± 0.83

3.02 ± 1.04

0.118

 T2

2.50 ± 0.69

2.86 ± 0.77

0.038

 P value

< 0.001a, b

< 0.001a, b

 

 ∆ PD (T0-T1)

3.26 ± 0.91

2.54 ± 0.79

0.001

 ∆ PD (T0-T2)

3.42 ± 0.80

2.70 ± 0.89

< 0.001

CAL (mm)

   

 T0

6.02 ± 1.12

5.64 ± 1.11

0.064

 T1

2.87 ± 0.90

3.22 ± 1.24

0.197

 T2

2.70 ± 0.72

3.10 ± 1.00

0.125

 P value

< 0.001a, b

< 0.001a, b

 

 ∆ CAL (T0-T1)

3.17 ± 0.90

2.42 ± 0.69

0.001

 ∆ CAL (T0-T2)

3.32 ± 0.78

2.54 ± 0.80

0.001

  1. Statistically significant differences are indicated in bold (P < 0.05 and P < 0.001)
  2. a Significant difference between baseline and the first month, b significant difference between baseline and the third month
  3. T0: Baseline, T1: First month, T2: Third month, ∆: Changes in clinical parameters during the study period